Back
Vertex Pharmaceuticals Stock Price Chart
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]
Sell
41
VRTX
Vertex Pharmaceuticals
Last Price:
$422.14
Seasonality Move:
-3.66%
7 Day Trial
ALL ACCESS PASS
$
7
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]-
The current trend is relatively stagnant and VRTX is experiencing slight selling pressure.
Vertex Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 414.78 | Buy |
| 20-day SMA: | 410.5 | Buy |
| 50-day SMA: | 447.46 | Sell |
| 200-day SMA: | 456.84 | Sell |
| 8-day EMA: | 416 | Buy |
| 20-day EMA: | 419.77 | Buy |
| 50-day EMA: | 437.76 | Sell |
| 200-day EMA: | 446.58 | Sell |
Vertex Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -8.13 | Sell |
| Relative Strength Index (14 RSI): | 48.34 | Sell |
| Chaikin Money Flow: | -669484 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (397.17 - 446.31) | Buy |
| Bollinger Bands (100): | (432.43 - 488.77) | Sell |
Vertex Pharmaceuticals Technical Analysis
| Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vertex Pharmaceuticals Stock
Is Vertex Pharmaceuticals Stock a Buy?
-
Vertex Pharmaceuticals share price is 422.00 while VRTX 8-day simple moving average is 414.78, which is a Buy signal.
-
The stock price of VRTX is 422.00 while Vertex Pharmaceuticals 20-day SMA is 410.50, which makes it a Buy.
-
Vertex Pharmaceuticals 50-day simple moving average is 447.46 while VRTX share price is 422.00, making it a Sell technically.
-
VRTX stock price is 422.00 and Vertex Pharmaceuticals 200-day simple moving average is 456.84, creating a Sell signal.
VRTX Technical Analysis vs Fundamental Analysis
Sell
41
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a SellThe current Vertex Pharmaceuticals [VRTX] share price is $422.00. The Score for VRTX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Vertex Pharmaceuticals Stock Info
Market Cap:
108.7B
Price in USD:
422.00
Share Volume:
1.7M
Vertex Pharmaceuticals 52-Week Range
52-Week High:
519.88
52-Week Low:
377.85
Sell
41
Vertex Pharmaceuticals (VRTX)
is a Sell
Vertex Pharmaceuticals Share Price Forecast
-
What is the Vertex Pharmaceuticals stock price today?The Vertex Pharmaceuticals stock price is 422.00 USD today.
-
Will VRTX stock go up or go down?Vertex Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Vertex Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vertex Pharmaceuticals is overvalued.
Is Vertex Pharmaceuticals Stock a Buy?
-
Vertex Pharmaceuticals share price is 422.00 while VRTX 8-day exponential moving average is 416.00, which is a Buy signal.
-
The stock price of VRTX is 422.00 while Vertex Pharmaceuticals 20-day EMA is 419.77, which makes it a Buy.
-
Vertex Pharmaceuticals 50-day exponential moving average is 437.76 while VRTX share price is 422.00, making it a Sell technically.
-
VRTX stock price is 422.00 and Vertex Pharmaceuticals 200-day simple moving average is 446.58, creating a Sell signal.
Fundamental Analysis of Vertex Pharmaceuticals
Is Vertex Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.51 per share, a decrease next quarter of $0.00 per share, an increase this year of $18.22 per share, and an increase next year of $2.05 per share.
Technical Analysis of Vertex Pharmaceuticals
Should I short Vertex Pharmaceuticals stock?
-
VRTX Moving Average Covergence Divergence (MACD) indicator is -8.13, suggesting Vertex Pharmaceuticals is a Sell
-
Vertex Pharmaceuticals Relative Strength Index (RSI) is 48.34, which suggest Vertex Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Vertex Pharmaceuticals is (397.17 - 446.31), which suggest Vertex Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Vertex Pharmaceuticals is (432.43 - 488.77), which suggest Vertex Pharmaceuticals is a Sell
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.